Pura Vida Investments’s Collegium Pharmaceutical COLL Stock Holding History

Pura Vida Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-52,219	Closed	-$1.25M	–	113
2018 Q2	$1.25M	Buy	+52,219	New	+$1.28M	0.5%	63
2017 Q4	–	Sell	-117,131	Closed	-$1.23M	–	77
2017 Q3	$1.23M	Buy	+117,131	New	+$1.29M	0.36%	65
2017 Q2	–	Sell	-200,000	Closed	-$2.01M	–	75
2017 Q1	$2.01M	Buy	+200,000	New	+$2.97M	0.6%	52

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's COLL Position: Q3 2018 in Review

Pura Vida Investments sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 52,219 shares — an estimated $1.25M sold.

Pura Vida Investments first reported a position in COLL in Q1 2017 and held it in 3 quarters. The position peaked at $2.01M in Q1 2017. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

Pura Vida Investments reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Pura Vida Investments sold 52,219 Collegium Pharmaceutical shares in Q3 2018, an estimated $1.25M.
Pura Vida Investments first reported a position in Collegium Pharmaceutical in Q1 2017 and held it in 3 quarters.
Pura Vida Investments's Collegium Pharmaceutical position peaked at $2.01M in Q1 2017.
124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Pura Vida Investments's 13F filing for Q3 2018, filed 14 Nov 2018.